PSAERSPCReasons for and against screening of,prostate cancer have been discussed widely over the last decade.In 2014,the European Randomized Trial for Screening of Prostate Cancer(ERSPC)has reported a relative reduction of the cancer-specific survival of 27%in participants who definitely followed the...
There are two standard types of prostate cancer screening tests: Prostate-Specific Antigen (PSA) test - a blood test that measures the level of PSA in the blood. PSA is a protein made by the prostate. The higher your level of PSA, the more likely you are to have prostate cancer. Howeve...
Latner, Ann W
Several questions and answers on non-screening Prostate-Specific Antigen (PSA) covered by medicare are presented including one on checking PSA in a patient on testosterone therapy, pre-authorization for ...
and difficulties with clinical screening and translation are the key barriers to synthetic lethality. Recent studies have shown that cancer cells with altered DNA repair mechanisms are ideal candidates for therapies based on synthetic lethality approaches. According to this viewpoint, pharmacological combina...